paclitaxeltrastuzumabramucirumabevorpaceptevoevo-TRPevo-basedTRPHER2-overexpressing gastric/gastroesophageal cancer (GC)
…d PFS in combination with trastuzumab (T), ramucirumab (R), and paclitaxel (P) in advanced, previously treated HER2+ gastric/gastroesophag…